04 Apr, 10:09 - Indian

SENSEX 75537.83 (-0.99)

Nifty 50 22967.35 (-1.22)

Nifty Bank 51553.85 (-0.08)

Nifty IT 33930.75 (-2.38)

Nifty Midcap 100 50891.85 (-2.44)

Nifty Next 50 61870.35 (-1.96)

Nifty Pharma 20375.65 (-4.89)

Nifty Smallcap 100 15823.55 (-2.66)

04 Apr, 10:09 - Global

NIKKEI 225 33443.42 (-3.72)

HANG SENG 22849.81 (-1.52)

S&P 5400.75 (-0.81)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoSakar Healthcare Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 538377 | NSE Symbol : SAKAR | ISIN : INE732S01012 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
01-Feb-2025 08-Feb-2025 Quarterly Results To consider and approve the financial results for the period ended December 31, 2024 Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on February 08, 2025. (As Per NSE Announcement Dated on: 08.02.2025)
17-Oct-2024 22-Oct-2024 Quarterly Results This is to inform you that the next Meeting of the Board of Directors of the Company to consider and take on record the Unaudited Financial Results for the Quarter ended on 30th September, 2024 is scheduled to be held on 22nd October, 2024. Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on October 22, 2024. (As Per NSE Announcement Dated on: 22/10/2024)
08-Aug-2024 13-Aug-2024 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2024 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2024. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on August 13, 2024. (As Per NSE Announcement Dated on: 13/08/2024)
22-Jul-2024 22-Jul-2024 AGM Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on July 22, 2024.
14-May-2024 21-May-2024 Quarterly Results To consider and approve the financial results for the period ended March 31, 2024 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2024. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on May 21, 2024. (As Per NSE Announcement Dated on: 21/05/2024)
02-Feb-2024 10-Feb-2024 Quarterly Results To consider and approve the financial results for the period ended December 31, 2023 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on February 10, 2024. As Per NSE Announcement Dated on: 10/02/2024)
16-Nov-2023 21-Nov-2023 Preferential Issue To consider Fund Raising and other business matters Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 21, 2023. (As Per NSE Announcement Dated on: 21/11/2023)
31-Oct-2023 06-Nov-2023 Quarterly Results To consider and approve the financial results for the period ended September 30, 2023 and other business matters Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on November 06, 2023. (As Per NSE Announcement Dated on:06/11/2023)
01-Sep-2023 01-Sep-2023 Change in Directors Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on September 01, 2023.
07-Aug-2023 14-Aug-2023 Quarterly Results To consider and approve the financial results for the period ended Jun 30, 2023 SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on August 14, 2023. (As Per NSE Announcement Dated on 14/08/2023) Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication (As Per NSE Announcement Dated on 17/08/2023)
30-Jul-2023 03-Aug-2023 Preferential Issue To consider Fund Raising and other business matters SAKAR HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 03-Aug-2023 to consider and approve Fund raising/Increase in authorised capital/Other business. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on August 03, 2023. Sakar Healthcare Limited has informed the Exchange about Board has approved to create, offer, issue and allot up to 23,09,910 Equity shares at an issue price of Rs. 259.75/- per equity shares on a preferential basis to Non-Promoter Group Category i.e. Tata Capital Healthcare Fund II. Sakar Healthcare Limited has informed the Exchange about Board has approved the execution of a share subscription agreement dated August 3, 2023 between the Company, Tata Capital Healthcare Fund II (acting through its trustee Tata Trustee Company Private Limited) and the promoters listed in Annexure B ( SSA ) (As Per NSE Announcement Dated on 03/08/2023)
20-Jul-2023 20-Jul-2023 AGM Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on July 20, 2023. Sakar Healthcare Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 15-Sep-2023 to 21-Sep-2023 for the purpose of Annual General Meeting.
19-May-2023 26-May-2023 Accounts To consider and approve the financial results for the period ended March 31, 2023 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on May 26, 2023. (As Per NSE Announcement Dated on 26/05/2023)
24-Feb-2023 24-Feb-2023 Preferential Issue Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on February 24, 2023 for Allotment of Equity Shares on Preferential Basis. Sakar Healthcare Limited has informed the Exchange regarding allotment of 422000 Equity Shares pursuant to Preferential Issue at its meeting held on February 24, 2023
01-Feb-2023 10-Feb-2023 Quarterly Results SAKAR HEALTHCARE LIMITEDhas informed the Exchange about Board Meeting to be held on 10-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 Sakar Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022. Sakar Healthcare Limited has informed the Exchange regarding Board meeting held on February 10, 2023. (As Per NSE Announcement Dated on 10/02/2023) The Exchange had sought clarification from Sakar Healthcare Limited for the quarter ended 31-Dec-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. (As Per NSE Announcement Dated on 03/03/2023)
1 2 3 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +